Panacea Life Sciences Holdings, Inc. (PLSH) Research

Panacea Life Sciences Holdings, Inc. operates as an integrated research and production firm, specializing in cannabinoid and nutraceutical products across the entire supply chain, from sourcing to final sale. Its core mission is to develop and deliver natural, pharmaceutical-grade alternatives for both human and pet consumption. The company's diverse product range encompasses items such as softgels, edible gummies, liquid tinctures, sublingual tablets, and a variety of cosmetic and topical applications. In addition to these offerings, the company is involved in the personal protective equipment (PPE) market, importing and distributing hand sanitizers and masks. Panacea Life Sciences also provides white-label and contract manufacturing services to other cannabinoid companies, sells raw materials, and manages tolling arrangements. Established in 2008, the company is headquartered in Greenwood Village, Colorado.

Market snapshot

Symbol
PLSH
Price
$0.04
Day change
0.00%
Market cap
$742.8K
P/E ratio
-0.52x
52-week range
0.0211-0.1996
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic

Peer companies

  • Allied Corp. (ALID)
  • Aion Therapeutic Inc. (ANTCF)
  • Bhang Inc. (BHNGF)
  • Target Group Inc. (CBDY)
  • Cann American Corp. (CNNA)
  • Anything Technologies Media, Inc. (EXMT)
  • James E. Wagner Cultivation Corporation (JWCAF)
  • Resonate Blends, Inc. (KOAN)

Recent insider activity

  • Buttorff Leslie — P-Purchase (20000 shares) on 2023-09-18
  • Buttorff Leslie — P-Purchase (3000 shares) on 2023-06-09
  • Buttorff Leslie — A-Award (760000 shares) on 2023-06-02
  • Buttorff Leslie — P-Purchase (500 shares) on 2023-05-23
  • Buttorff Leslie — P-Purchase (1500 shares) on 2023-05-19

Open Panacea Life Sciences Holdings, Inc. (PLSH) in Thesis for live fundamentals, charts, options context, and portfolio-aware Copilot follow-ups.